← Back to Search
Expression Of Peroxiredoxin And Thioredoxin In Human Lung Cancer And Paired Normal Lung
Joohun Park, Y. Kim, Hye Lim Lee, J. Shim, K. Lee, Y. Oh, S. S. Shin, Y. H. Choi, K. Park, Rae Woong Park, S. Hwang
Published 2006 · Biology
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Background: Peroxiredoxins (Prxs) have been implicated in regulating many cellular processes including cell proliferation, differentiation and apoptosis. However, the pathophysiological significance of Prx proteins, especially in lung disease, has not been defined. Therefore, the authors investigated the distribution and expression of various Prx isoforms in lung cancer and compared this with normal lung from human and mouse.
This paper references
Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae.
H. Chae (1993)
Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes.
H. Z. Chae (1994)
A thiol-specific antioxidant and sequence homology to various proteins of unknown function.
Chae Hz (1994)
Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction.
C. Marshall (1996)
Peroxiredoxin I expression in human thyroid tumors.
T. Yanagawa (1999)
Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury.
E. Abraham (2000)
Oxidants, oxidative stress and the biology of ageing
T. Finkel (2000)
NADPH oxidase: a universal oxygen sensor?
R. Jones (2000)
Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation1
E. Abraham (2000)
Antisense of human peroxiredoxin II enhances radiation-induced cell death.
S. Park (2000)
Role of redox-regulated transcription factors in inflammation, aging and age-related diseases
Y. Lavrovsky (2000)
Redox signaling in macrophages.
H. J. Forman (2001)
Overexpression of peroxiredoxin in human breast cancer.
D. Y. Noh (2001)
Regulation of thioredoxin peroxidase activity by C-terminal truncation.
Kyung Hee Koo (2002)
Cellular regulation by hydrogen peroxide.
S. Rhee (2003)
Nuclear Factor—κB and Its Role in Sepsis-Associated Organ Failure
E. Abraham (2003)
ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin
B. Biteau (2003)
Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells.
S. Lee (2003)
Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid
NADPH oxidase in human lung fibroblasts
G. Dhaunsi (2004)
Novel NAD(P)H oxidases in the cardiovascular system
K. Griendling (2004)
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
T. Chang (2004)
Retrovirally mediated overexpression of peroxiredoxin VI increases the survival of WI-38 human diploid fibroblasts exposed to cytotoxic doses of tert-butylhydroperoxide and UVB
Jean-Fran¸ois Dierick (2004)
Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues
H. Kim (2003)
Two Enzymes in One Two Yeast Peroxiredoxins Display Oxidative Stress-Dependent Switching from a Peroxidase to a Molecular Chaperone Function
H. H. Jang (2004)
An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems.
J. Stone (2004)
Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD
A. Budanov (2004)
This paper is referenced by
Pulmonary Exposure to Copper Oxide Nanoparticles Leads to Neurotoxicity via Oxidative Damage and Mitochondrial Dysfunction.
Hongmei Zhou (2021)
Epidemiologic evidence linking oxidative stress and pulmonary function in healthy populations
L. Okeleji (2021)
Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology
J. Checa (2020)
PRDX1 Counteracts Catastrophic Telomeric Cleavage Events That Are Triggered by DNA Repair Activities Post Oxidative Damage.
Wareed Ahmed (2020)
Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.
E. Elko (2019)
Catalytic and Signaling Role of Peroxiredoxins in Carcinogenesis
M. Sharapov (2019)
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim (2019)
Oxidative stress in diffuse large B-cell lymphoma and follicular lymphoma, and TP53 mutations and translocations of MYC, Bcl-2 and Bcl-6 in diffuse large B-cell lymphoma
P. Peroja (2018)
Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease
Samia Boukhenouna (2018)
Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation
Yoon Min (2018)
Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin.
M. B. Cerda (2017)
Quantification of the thioredoxin system.
Padayachee. Letrisha (2017)
Proteostasis and Aging in Saccharomyces cerevisiae - The role of a Peroxiredoxin
S. Hanzén (2017)
The Multifaceted Roles of DJ-1 as an Antioxidant.
Prahlad V. Raninga (2017)
Proteomic responses of BEAS-2B cells to nontoxic and toxic chromium: Protein indicators of cytotoxicity conversion.
M. Bruno (2016)
Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase.
C. Myers (2016)
Silencing PRDX3 Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells.
Zhilei Liu (2016)
Lifespan Control by Redox-Dependent Recruitment of Chaperones to Misfolded Proteins
S. Hanzén (2016)
Antioxidant Defenses in the Lung
A. Vliet (2015)
Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.
Guoquan Li (2015)
Elucidation of thioredoxin reductase 1 as an anticancer drug target
William C. Stafford (2015)
Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling.
A. Schmitt (2015)
The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells
Lianqin Li (2015)
Proteomic analysis identifies differentially expressed proteins after red propolis treatment in Hep-2 cells.
Caroline Olivieri da Silva Frozza (2014)
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
A. Nicolussi (2014)
Proteomics biomarkers for non-small cell lung cancer.
J. Kiśluk (2014)
Myeloperoxidase-derived oxidants: their Intracellular targets, defence mechanisms and role in disease
Polina E Nedoboy (2014)
Long-term study of ovine pulmonary adenocarcinogenesis in sheep with marginal vs. sufficient nutritional selenium supply: results from computed tomography, pathology, immunohistochemistry, JSRV-PCR and lung biochemistry.
E. Humann-Ziehank (2013)
Proteomic biomarkers in lung cancer
M. D. Pastor (2013)
II. Medizinische Klinik und Poliklinik - Onkologie, Hämatologie, Knochenmarktransplantation mit der Sektion Pneumologie
Carsten Bokemeyer (2013)
Studies on In Vivo Function of Peroxiredoxins in Knockout Mice
D. yU (2013)
Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.
Young-Ho Park (2013)See more